nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—MPO—Calcipotriol—psoriasis	0.34	0.395	CbGbCtD
Oxaliplatin—CYP1A1—Clobetasol propionate—psoriasis	0.0992	0.115	CbGbCtD
Oxaliplatin—CYP1A1—Methoxsalen—psoriasis	0.0521	0.0605	CbGbCtD
Oxaliplatin—CYP1A2—Clobetasol propionate—psoriasis	0.0443	0.0514	CbGbCtD
Oxaliplatin—ABCC2—Mycophenolate mofetil—psoriasis	0.0359	0.0416	CbGbCtD
Oxaliplatin—CYP1A1—Cholecalciferol—psoriasis	0.0345	0.0401	CbGbCtD
Oxaliplatin—CYP1B1—Dexamethasone—psoriasis	0.034	0.0395	CbGbCtD
Oxaliplatin—ABCG2—Mycophenolate mofetil—psoriasis	0.0324	0.0376	CbGbCtD
Oxaliplatin—ABCC2—Cyclosporine—psoriasis	0.0272	0.0315	CbGbCtD
Oxaliplatin—ABCG2—Hydrocortisone—psoriasis	0.026	0.0302	CbGbCtD
Oxaliplatin—ABCG2—Cyclosporine—psoriasis	0.0246	0.0285	CbGbCtD
Oxaliplatin—CYP1A2—Methoxsalen—psoriasis	0.0233	0.027	CbGbCtD
Oxaliplatin—ABCC2—Dexamethasone—psoriasis	0.0179	0.0208	CbGbCtD
Oxaliplatin—ABCG2—Dexamethasone—psoriasis	0.0162	0.0188	CbGbCtD
Oxaliplatin—CYP1A1—Dexamethasone—psoriasis	0.0149	0.0173	CbGbCtD
Oxaliplatin—ABCC2—Methotrexate—psoriasis	0.0144	0.0167	CbGbCtD
Oxaliplatin—ABCG2—Methotrexate—psoriasis	0.013	0.0151	CbGbCtD
Oxaliplatin—CYP2E1—Dexamethasone—psoriasis	0.0115	0.0134	CbGbCtD
Oxaliplatin—ATP7A—endothelium—psoriasis	0.00206	0.181	CbGeAlD
Oxaliplatin—MPO—endothelium—psoriasis	0.0011	0.0973	CbGeAlD
Oxaliplatin—MT2A—skin of body—psoriasis	0.00102	0.0895	CbGeAlD
Oxaliplatin—CYP1A1—skin epidermis—psoriasis	0.000822	0.0724	CbGeAlD
Oxaliplatin—GSTM1—skin of body—psoriasis	0.000732	0.0645	CbGeAlD
Oxaliplatin—ATP7A—tendon—psoriasis	0.000669	0.059	CbGeAlD
Oxaliplatin—SOD1—tendon—psoriasis	0.000586	0.0516	CbGeAlD
Oxaliplatin—SLC31A1—tendon—psoriasis	0.000571	0.0503	CbGeAlD
Oxaliplatin—NQO1—skin of body—psoriasis	0.000513	0.0452	CbGeAlD
Oxaliplatin—MPO—skin of body—psoriasis	0.000472	0.0416	CbGeAlD
Oxaliplatin—GSTP1—skin of body—psoriasis	0.000458	0.0404	CbGeAlD
Oxaliplatin—NQO1—tendon—psoriasis	0.00039	0.0344	CbGeAlD
Oxaliplatin—CYP1B1—skin of body—psoriasis	0.00036	0.0317	CbGeAlD
Oxaliplatin—GSTP1—tendon—psoriasis	0.000349	0.0307	CbGeAlD
Oxaliplatin—ABCC2—tendon—psoriasis	0.00028	0.0247	CbGeAlD
Oxaliplatin—CYP1B1—tendon—psoriasis	0.000274	0.0242	CbGeAlD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—CARM1—psoriasis	0.000268	0.00211	CbGpPWpGaD
Oxaliplatin—CA4—tendon—psoriasis	0.000266	0.0234	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CD4—psoriasis	0.000265	0.00209	CbGpPWpGaD
Oxaliplatin—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000259	0.00204	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—TNF—psoriasis	0.000258	0.00203	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-B—psoriasis	0.000258	0.00203	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—IFNG—psoriasis	0.000258	0.00203	CbGpPWpGaD
Oxaliplatin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000257	0.00202	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000257	0.00202	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—TYK2—psoriasis	0.000255	0.00201	CbGpPWpGaD
Oxaliplatin—CYP1A1—skin of body—psoriasis	0.000255	0.0224	CbGeAlD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000254	0.00199	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL6—psoriasis	0.000253	0.00199	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000251	0.00197	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ERAP1—psoriasis	0.000248	0.00195	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CYP2S1—psoriasis	0.000246	0.00194	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—STAT3—psoriasis	0.000243	0.00191	CbGpPWpGaD
Oxaliplatin—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000241	0.0019	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-A—psoriasis	0.000239	0.00188	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—IFNG—psoriasis	0.000239	0.00188	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000238	0.00188	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000238	0.00188	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000238	0.00187	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—NFKB1—psoriasis	0.000236	0.00185	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL6—psoriasis	0.000235	0.00185	CbGpPWpGaD
Oxaliplatin—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000227	0.00179	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CD4—psoriasis	0.000226	0.00177	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—TNF—psoriasis	0.000225	0.00177	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—IFNG—psoriasis	0.000225	0.00177	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000224	0.00177	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—TP53—psoriasis	0.000224	0.00176	CbGpPWpGaD
Oxaliplatin—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000224	0.00176	CbGpPWpGaD
Oxaliplatin—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000221	0.00174	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—DDX58—psoriasis	0.000218	0.00172	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	0.000218	0.00172	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—TGFA—psoriasis	0.000215	0.00169	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—NFKB1—psoriasis	0.000215	0.00169	CbGpPWpGaD
Oxaliplatin—CYP1B1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000213	0.00168	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriasis	0.000213	0.00167	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet degranulation—VEGFA—psoriasis	0.00021	0.00165	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TNF—psoriasis	0.00021	0.00165	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—ICAM1—psoriasis	0.00021	0.00165	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—IL6—psoriasis	0.000208	0.00164	CbGpPWpGaD
Oxaliplatin—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000208	0.00164	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—ITGAL—psoriasis	0.000202	0.00159	CbGpPWpGaD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.0002	0.00157	CbGpPWpGaD
Oxaliplatin—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000196	0.00154	CbGpPWpGaD
Oxaliplatin—SLC22A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000195	0.00153	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CAT—psoriasis	0.000193	0.00152	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—NFKB1—psoriasis	0.000187	0.00147	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—NDUFA5—psoriasis	0.000187	0.00147	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TP53—psoriasis	0.000185	0.00146	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TNF—psoriasis	0.000183	0.00144	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—IL6—psoriasis	0.000182	0.00143	CbGpPWpGaD
Oxaliplatin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000179	0.00141	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000177	0.00139	CbGpPWpGaD
Oxaliplatin—CYP2E1—tendon—psoriasis	0.000177	0.0156	CbGeAlD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—TYK2—psoriasis	0.00017	0.00134	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—IL6—psoriasis	0.00017	0.00133	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000169	0.00133	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CAT—psoriasis	0.000168	0.00132	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—TNF—psoriasis	0.000167	0.00131	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ITGAL—psoriasis	0.000166	0.0013	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—NDUFA5—psoriasis	0.000166	0.0013	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CXCL8—psoriasis	0.000165	0.0013	CbGpPWpGaD
Oxaliplatin—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000165	0.0013	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000162	0.00127	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TP53—psoriasis	0.000162	0.00127	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IFNG—psoriasis	0.00016	0.00125	CbGpPWpGaD
Oxaliplatin—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000159	0.00125	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CYP2S1—psoriasis	0.000159	0.00125	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—NDUFA5—psoriasis	0.000159	0.00125	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000157	0.00124	CbGpPWpGaD
Oxaliplatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000155	0.00122	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	0.000155	0.00122	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—REL—psoriasis	0.000155	0.00122	CbGpPWpGaD
Oxaliplatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000155	0.00122	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—NDUFA5—psoriasis	0.000155	0.00122	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—JUN—psoriasis	0.000154	0.00121	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000153	0.0012	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IFIH1—psoriasis	0.00015	0.00118	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—NFKB1—psoriasis	0.000148	0.00116	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IL6—psoriasis	0.000148	0.00116	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000147	0.00116	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—TNF—psoriasis	0.000146	0.00115	CbGpPWpGaD
Oxaliplatin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000145	0.00114	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000143	0.00113	CbGpPWpGaD
Oxaliplatin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000143	0.00112	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-C—psoriasis	0.000143	0.00112	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—TNFAIP3—psoriasis	0.000141	0.00111	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CYP2S1—psoriasis	0.000141	0.00111	CbGpPWpGaD
Oxaliplatin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000141	0.00111	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CYP2S1—psoriasis	0.000135	0.00106	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—IL6—psoriasis	0.000135	0.00106	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—VEGFA—psoriasis	0.000134	0.00106	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000134	0.00105	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—STAT3—psoriasis	0.000133	0.00105	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—NFKB1—psoriasis	0.000133	0.00104	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CYP2S1—psoriasis	0.000131	0.00103	CbGpPWpGaD
Oxaliplatin—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000131	0.00103	CbGpPWpGaD
Oxaliplatin—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000128	0.001	CbGpPWpGaD
Oxaliplatin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000125	0.000984	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000122	0.000962	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CARM1—psoriasis	0.00012	0.000946	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	0.00012	0.000943	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—STAT3—psoriasis	0.000119	0.000938	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-E—psoriasis	0.000118	0.00093	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—IL6—psoriasis	0.000118	0.000924	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000115	0.000901	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000115	0.000901	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000114	0.000897	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000109	0.000857	CbGpPWpGaD
Oxaliplatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000108	0.000849	CbGpPWpGaD
Oxaliplatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000107	0.000843	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—NDUFA5—psoriasis	0.000107	0.000839	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	0.000104	0.00082	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—psoriasis	0.000101	0.000798	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CXCL8—psoriasis	9.96e-05	0.000783	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—CP—psoriasis	9.91e-05	0.00078	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—SOCS1—psoriasis	9.88e-05	0.000777	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—CARM1—psoriasis	9.46e-05	0.000744	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	9.42e-05	0.000741	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—psoriasis	9.32e-05	0.000733	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—IL6—psoriasis	9.29e-05	0.000731	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—JUN—psoriasis	9.25e-05	0.000728	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	9.11e-05	0.000717	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.07e-05	0.000713	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CYP2S1—psoriasis	9.07e-05	0.000713	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—NFKB1—psoriasis	8.91e-05	0.000701	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD8A—psoriasis	8.76e-05	0.000689	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CXCL8—psoriasis	8.69e-05	0.000683	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-B—psoriasis	8.43e-05	0.000663	CbGpPWpGaD
Oxaliplatin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	8.36e-05	0.000658	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL6—psoriasis	8.33e-05	0.000655	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—NOS2—psoriasis	8.3e-05	0.000653	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	8.23e-05	0.000648	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—VEGFA—psoriasis	8.09e-05	0.000636	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—JUN—psoriasis	8.08e-05	0.000635	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—STAT3—psoriasis	8.01e-05	0.00063	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-A—psoriasis	7.81e-05	0.000614	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—NFKB1—psoriasis	7.77e-05	0.000611	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CARM1—psoriasis	7.75e-05	0.00061	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CRP—psoriasis	7.45e-05	0.000586	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—NDUFA5—psoriasis	7.43e-05	0.000584	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CAT—psoriasis	7.4e-05	0.000582	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	7.22e-05	0.000568	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-DRB1—psoriasis	7.13e-05	0.000561	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—VEGFA—psoriasis	7.05e-05	0.000555	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.05e-05	0.000555	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.05e-05	0.000555	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—STAT3—psoriasis	6.99e-05	0.00055	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.95e-05	0.000547	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.93e-05	0.000545	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	6.89e-05	0.000542	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CARM1—psoriasis	6.87e-05	0.000541	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ICAM1—psoriasis	6.85e-05	0.000539	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—NFKBIA—psoriasis	6.79e-05	0.000534	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—NDUFA5—psoriasis	6.76e-05	0.000532	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—NDUFA5—psoriasis	6.69e-05	0.000526	CbGpPWpGaD
Oxaliplatin—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	6.61e-05	0.00052	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CARM1—psoriasis	6.59e-05	0.000518	CbGpPWpGaD
Oxaliplatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	6.47e-05	0.000509	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CARM1—psoriasis	6.42e-05	0.000505	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CYP2S1—psoriasis	6.32e-05	0.000497	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	6.28e-05	0.000494	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—NDUFA5—psoriasis	6.24e-05	0.000491	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	6.22e-05	0.000489	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—psoriasis	6.11e-05	0.000481	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.01e-05	0.000473	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	5.99e-05	0.000471	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.93e-05	0.000467	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	5.79e-05	0.000456	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.78e-05	0.000455	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CYP2S1—psoriasis	5.75e-05	0.000452	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—APOE—psoriasis	5.75e-05	0.000452	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CYP2S1—psoriasis	5.69e-05	0.000447	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—IL6—psoriasis	5.59e-05	0.00044	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—TYK2—psoriasis	5.56e-05	0.000438	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	5.53e-05	0.000435	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—psoriasis	5.33e-05	0.000419	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CYP2S1—psoriasis	5.3e-05	0.000417	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.25e-05	0.000413	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IFNG—psoriasis	5.21e-05	0.00041	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD4—psoriasis	5.03e-05	0.000396	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PPARG—psoriasis	5.01e-05	0.000394	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—IL6—psoriasis	4.88e-05	0.000384	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—NDUFA5—psoriasis	4.85e-05	0.000382	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—VEGFA—psoriasis	4.8e-05	0.000378	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CAT—psoriasis	4.77e-05	0.000375	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—NDUFA5—psoriasis	4.58e-05	0.00036	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—JUN—psoriasis	4.5e-05	0.000354	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.5e-05	0.000354	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.5e-05	0.000354	CbGpPWpGaD
Oxaliplatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	4.46e-05	0.000351	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CARM1—psoriasis	4.43e-05	0.000348	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—NFKB1—psoriasis	4.34e-05	0.000341	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.27e-05	0.000336	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CAT—psoriasis	4.23e-05	0.000333	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CYP2S1—psoriasis	4.13e-05	0.000325	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CAT—psoriasis	4.05e-05	0.000319	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CAT—psoriasis	3.95e-05	0.000311	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—STAT3—psoriasis	3.9e-05	0.000306	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CYP2S1—psoriasis	3.89e-05	0.000306	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—APOE—psoriasis	3.7e-05	0.000291	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—psoriasis	3.63e-05	0.000286	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.31e-05	0.00026	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—APOE—psoriasis	3.28e-05	0.000258	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PPARG—psoriasis	3.23e-05	0.000254	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—APOE—psoriasis	3.15e-05	0.000248	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CARM1—psoriasis	3.09e-05	0.000243	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—APOE—psoriasis	3.07e-05	0.000241	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—NDUFA5—psoriasis	2.92e-05	0.00023	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.88e-05	0.000227	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PPARG—psoriasis	2.86e-05	0.000225	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CARM1—psoriasis	2.81e-05	0.000221	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CARM1—psoriasis	2.78e-05	0.000219	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PPARG—psoriasis	2.74e-05	0.000216	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CAT—psoriasis	2.72e-05	0.000214	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL6—psoriasis	2.72e-05	0.000214	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.72e-05	0.000214	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PPARG—psoriasis	2.67e-05	0.00021	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CARM1—psoriasis	2.59e-05	0.000204	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CYP2S1—psoriasis	2.48e-05	0.000195	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—APOE—psoriasis	2.12e-05	0.000167	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.04e-05	0.00016	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CARM1—psoriasis	2.02e-05	0.000159	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CARM1—psoriasis	1.9e-05	0.000149	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CAT—psoriasis	1.9e-05	0.000149	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PPARG—psoriasis	1.84e-05	0.000145	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.78e-05	0.00014	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CAT—psoriasis	1.73e-05	0.000136	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CAT—psoriasis	1.71e-05	0.000134	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CAT—psoriasis	1.59e-05	0.000125	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—APOE—psoriasis	1.47e-05	0.000116	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—APOE—psoriasis	1.34e-05	0.000106	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—APOE—psoriasis	1.33e-05	0.000104	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.3e-05	0.000102	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PPARG—psoriasis	1.28e-05	0.000101	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CAT—psoriasis	1.24e-05	9.75e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—APOE—psoriasis	1.24e-05	9.73e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CARM1—psoriasis	1.21e-05	9.53e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CAT—psoriasis	1.17e-05	9.19e-05	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PPARG—psoriasis	1.17e-05	9.19e-05	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PPARG—psoriasis	1.16e-05	9.1e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.13e-05	8.91e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PPARG—psoriasis	1.08e-05	8.48e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—APOE—psoriasis	9.63e-06	7.58e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—APOE—psoriasis	9.08e-06	7.14e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PPARG—psoriasis	8.39e-06	6.6e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PPARG—psoriasis	7.91e-06	6.22e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CAT—psoriasis	7.45e-06	5.86e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—APOE—psoriasis	5.79e-06	4.55e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PPARG—psoriasis	5.04e-06	3.97e-05	CbGpPWpGaD
